印度第一个生育部门IPO,Gaudium IVF, 完全赞成, 提出165 crore,定于2月27日列入。 India's first fertility sector IPO, Gaudium IVF, fully subscribed, raised ₹165 crore, set to list Feb. 27.

印度生育领域首个IPO,即Gaudium IVF & Women Health Ltd的IPO于2026年2月23日完成, 总投标达到了1.95倍的投标规模. Gaudium IVF & Women Health Ltd's IPO, the first in India's fertility sector, closed fully subscribed on February 23, 2026, with total bids reaching 1.95 times the offer size. 零售投资者带动需求,订户2.81次,非机构投资者订户2.56次;合格的机构购买者表示兴趣最小。 Retail investors led demand, subscribing 2.81 times, while non-institutional investors subscribed 2.56 times; qualified institutional buyers showed minimal interest. IPO以每股75-79美分计价, 筹集165美分, 用于资助19个新的IVF中心、还债及一般需要。 The IPO, priced at ₹75–79 per share, raised ₹165 crore, with proceeds to fund 19 new IVF centers, debt repayment, and general needs. 该公司报告说,金融增长强劲,25财政年度的PAT增加85%至19.13克郎。 The company reported strong financial growth, with FY25 PAT up 85% to ₹19.13 crore. 灰色市场溢价8.50 表示可能上市收益约11%。 A grey market premium of ₹8.50 suggested a potential listing gain of about 11%. 该股票定于2月27日在BSE和NSE上列出。 The stock is set to list on BSE and NSE on February 27.